Review of different staging systems for cutaneous squamous cell carcinoma.

Linked Article: Venables et al. Br J Dermatol 2022; 186:835–842. Cutaneous squamous cell carcinoma (cSCC) is a type of skin cancer. It is very common. Nearly all cSCCs are low‐risk skin cancers and can be cured but a a small proportion spread elsewhere (2–5%) and are much more serious. Trying to predict which tumours are more likely to metastasize (spread elsewhere) is therefore very important. There are a few different staging systems to help predict a tumour's risk of spreading. In this study, the authors from the UK and the Netherlands used a national dataset of cSCC to assess the current staging systems to see how well they predict which ones are likely to spread. They found that overall, the Brigham Women's Hospital cSCC staging system performs best but there is potential for further improvement. This knowledge will help identify patients at highest risk of their cSCC spreading. Linked Article: Venables et al. Br J Dermatol 2022; 186:835–842. [ABSTRACT FROM AUTHOR]